Home/Filings/4/0001209191-18-047750

4//SEC Filing

LVP GP III, LLC 4

Accession 0001209191-18-047750

CIK 0001403708other

View on SEC.gov Company Profile

Filed

Aug 20, 8:00 PM ET

Accepted

Aug 21, 4:24 PM ET

Size

18.1 KB

Accession

0001209191-18-047750

Insider Transaction Report

Form 4

Period: 2018-08-20

Evoke Pharma IncEVOK

LVP GP III, LLC

10% Owner

Transactions

Purchase
Common Stock
2018-08-20$2.35/sh+465,116$1,093,023→ 1,937,983 total(indirect: Directly owned by LVP III)
Purchase
Common Stock
2018-08-20$2.35/sh+11,628$27,326→ 48,449 total(indirect: Directly owned by Partners)
Purchase
Common Stock
2018-08-20$2.35/sh+23,256$54,652→ 96,897 total(indirect: Directly owned by Associates)

Holdings

Common Stock
(indirect: Directly owned by LVPMC)
5,250

LATTERELL PATRICK F

10% Owner

Transactions

Purchase
Common Stock
2018-08-20$2.35/sh+23,256$54,652→ 96,897 total(indirect: Directly owned by Associates)
Purchase
Common Stock
2018-08-20$2.35/sh+465,116$1,093,023→ 1,937,983 total(indirect: Directly owned by LVP III)
Purchase
Common Stock
2018-08-20$2.35/sh+11,628$27,326→ 48,449 total(indirect: Directly owned by Partners)

Holdings

Common Stock
(indirect: Directly owned by LVPMC)
5,250

LVP III Associates, L.P.

10% Owner

Transactions

Purchase
Common Stock
2018-08-20$2.35/sh+23,256$54,652→ 96,897 total(indirect: Directly owned by Associates)
Purchase
Common Stock
2018-08-20$2.35/sh+465,116$1,093,023→ 1,937,983 total(indirect: Directly owned by LVP III)
Purchase
Common Stock
2018-08-20$2.35/sh+11,628$27,326→ 48,449 total(indirect: Directly owned by Partners)

Holdings

Common Stock
(indirect: Directly owned by LVPMC)
5,250

LVP III Partners LP

10% Owner

Transactions

Purchase
Common Stock
2018-08-20$2.35/sh+23,256$54,652→ 96,897 total(indirect: Directly owned by Associates)
Purchase
Common Stock
2018-08-20$2.35/sh+11,628$27,326→ 48,449 total(indirect: Directly owned by Partners)
Purchase
Common Stock
2018-08-20$2.35/sh+465,116$1,093,023→ 1,937,983 total(indirect: Directly owned by LVP III)

Holdings

Common Stock
(indirect: Directly owned by LVPMC)
5,250

LVPMC, LLC

10% Owner

Transactions

Purchase
Common Stock
2018-08-20$2.35/sh+11,628$27,326→ 48,449 total(indirect: Directly owned by Partners)
Purchase
Common Stock
2018-08-20$2.35/sh+465,116$1,093,023→ 1,937,983 total(indirect: Directly owned by LVP III)
Purchase
Common Stock
2018-08-20$2.35/sh+23,256$54,652→ 96,897 total(indirect: Directly owned by Associates)

Holdings

Common Stock
(indirect: Directly owned by LVPMC)
5,250

LVP LIFE SCIENCE VENTURES III L.P.

10% Owner

Transactions

Purchase
Common Stock
2018-08-20$2.35/sh+465,116$1,093,023→ 1,937,983 total(indirect: Directly owned by LVP III)
Purchase
Common Stock
2018-08-20$2.35/sh+23,256$54,652→ 96,897 total(indirect: Directly owned by Associates)
Purchase
Common Stock
2018-08-20$2.35/sh+11,628$27,326→ 48,449 total(indirect: Directly owned by Partners)

Holdings

Common Stock
(indirect: Directly owned by LVPMC)
5,250

Footnotes (1)

[F1]The reported securities are owned directly by each of LVPMC, LLC ("LVPMC"), LVP Life Science Ventures III, L.P. ("LVP III"), LVP III Associates, L.P. ("Associates") and LVP III Partners, L.P. ("Partners"). LVP GP III, LLC ("GP III") is the general partner of LVP III, Associates and Partners. GP III may be deemed to have sole voting power and dispositive power over the shares held by LVP III, Associates and Partners. Each of GP III and Patrick Latterell, the managing member of GP III and the manager of LVPMC, may be deemed to share voting and dispositive power over the reported securities and disclaim beneficial ownership of the reported securities held by LVPMC, LVP III, Associates and Partners except to the extent of any pecuniary interest therein.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Evoke Pharma Inc

CIK 0001403708

→

Entity typeother

IncorporatedDE

Related Parties

filerCIK 0001581469

Filing Metadata

Form type: 4
Filed: Aug 20, 8:00 PM ET
Accepted: Aug 21, 4:24 PM ET
Size: 18.1 KB

View on SEC.gov